Liminal BioSciences Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
1.06
|
|
Average Rating
|
2.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
0
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
1
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.14
|
-0.15
|
-0.01
|
-7.14%
|
|
2022-06-30
|
-0.19
|
-0.15
|
0.04
|
21.16%
|
|
2022-03-31
|
-0.20
|
-0.35
|
-0.15
|
-75.00%
|
|
2021-12-31
|
-0.40
|
-0.31
|
0.09
|
22.50%
|
|
2021-09-30
|
-0.34
|
2.74
|
3.08
|
905.88%
|
|
2021-06-30
|
-0.53
|
-1.07
|
-0.54
|
-101.89%
|
|
2021-03-31
|
-0.63
|
-0.68
|
-0.05
|
-7.94%
|
|
2020-12-31
|
-0.73
|
-1.45
|
-0.72
|
-98.63%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.65
|
|
2021-12-31
|
0.68
|
|
2020-12-31
|
-4.19
|
|
2019-12-31
|
67.25
|
|
2018-12-31
|
-155.13
|
|
2017-12-31
|
-140.04
|
|
2016-12-31
|
-0.17
|
|
2015-12-31
|
-17.37
|
|
2014-12-31
|
-30.02
|
|
2013-12-31
|
-39.49
|
|
2012-12-31
|
6.86
|
|
2011-12-31
|
-16.41
|
|
2010-12-31
|
-17.20
|
|
2009-12-31
|
-10.00
|
|
2007-12-31
|
-70.00
|
|
2005-12-31
|
-230.00
|